Helicobacter pyloriprevalence shows a wide range, with rates of 80% in developing countries. The infection with H. pyloricauses high morbidity and mortality worldwide. Current treatment regimens ...

Discover the effects of adding Helicobacter pylori stool antigen testing to colon cancer screening on rates of gastric cancer incidence and mortality.

Helicobacter pylori is a gram-negative bacterium that infects the stomach lining; it can cause gastrointestinal conditions such as gastritis or ulcers and can lead to an increased risk of stomach ...

Some estimates attribute as many as 20 percent of cancer cases to infectious agents, such as Epstein-Barr virus and hepatitis ...

A common stomach infection caused by Helicobacter pylori is known to lead to serious problems like ulcers and even stomach ...

TenNor Therapeutics has raised over 300 million yuan ($41 million) in a series E round, led by AMR Action Fund, to advance ...

pylori testing and treatment along with FIT would reduce ... Source Reference: Lee Y-C, et al "Screening for Helicobacter pylori to prevent gastric cancer: a pragmatic randomized clinical trial ...

Taiwanese medical researchers have developed the world’s first two-in-one stool test that simultaneously screens for stomach ...

Research analysts at StockNews.com started coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Get Free Report) ...

Application error: a client-side exception has occurred (see the browser console for more information).

P-CAB dual regimen ranks highest for efficacy and safety in first-line treatment of H pylori infection, according to study findings.